2025-05-02 11:23:29
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Indoco Remedies Ltd reports surge in Q1FY22 consolidated PAT to Rs. 39.66 crore
Posted On : 2021-08-11 13:07:47( TIMEZONE : IST )
Indoco Remedies Ltd. has reported financial results for the period ended June 30, 2021.
Financial Results (Q1 FY 2021-22) - QoQ Comparison
The company has reported total income of Rs.387.61 crores during the period ended June 30, 2021 as compared to Rs.307.12 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.39.66 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.25 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.4.30 for the period ended June 30, 2021 as compared to Rs.2.71 for the period ended March 31, 2021.
| Financials | Q1 FY2021-22 | Q4 FY20-21 | % Change |
| Total Income | ₹ 387.61 crs | ₹ 307.12 crs |  26.21% |
| Net Profit | ₹ 39.66 crs | ₹ 25 crs | 58.64% |
| EPS | ₹ 4.30 | ₹ 2.71 | 58.67% |
Financial Results (Q1 FY 2021-22) - YoY Comparison
The company has reported total income of Rs.387.61 crores during the period ended June 30, 2021 as compared to Rs.276.12 crores during the period ended June 30, 2020.
The company has posted net profit / (loss) of Rs.39.66 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.17.04 crores for the period ended June 30, 2020.
The company has reported EPS of Rs.4.30 for the period ended June 30, 2021 as compared to Rs.1.85 for the period ended June 30, 2020.
| Financials | Q1 FY2021-22 | Q1 FY2020-21 | % Change |
| Total Income | ₹ 387.61 crs | ₹ 276.12 crs | 40.38% |
| Net Profit | ₹ 39.66 crs | ₹ 17.04 crs | 132.75% |
| EPS | ₹ 4.30 | ₹ 1.85 | 132.43% |
Commenting on the first quarter FY22 results, Aditi Panandikar, Managing Director, Indoco Remedies Ltd., said, "Our India & International Businesses have shown a robust growth this quarter. We have optimised the opportunities presented by this very dynamic business environment as well as effectively adapted to the challenges thus presented".
Shares of Indoco Remedies Ltd. was last trading in BSE at Rs. 435 as compared to the previous close of Rs. 452.4. The total number of shares traded during the day was 16163 in over 1472 trades.
The stock hit an intraday high of Rs. 456 and intraday low of 425. The net turnover during the day was Rs. 7131432.
